Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
06/20/2025 | PUT | $820.00 | 4,250 | +2,400 | +129.73% |
06/20/2025 | CALL | $820.00 | 4,250 | +2,400 | +129.73% |
08/15/2025 | PUT | $760.00 | 375 | +229 | +156.85% |
06/20/2025 | PUT | $790.00 | 200 | +200 | |
06/20/2025 | CALL | $790.00 | 200 | +200 | |
05/30/2025 | CALL | $900.00 | 753 | +191 | +33.99% |
05/09/2025 | PUT | $827.50 | 42 | -58 | -58.00% |
05/09/2025 | PUT | $780.00 | 502 | -61 | -10.83% |
05/09/2025 | PUT | $815.00 | 246 | -85 | -25.68% |
07/18/2025 | CALL | $980.00 | 435 | -98 | -18.39% |
05/09/2025 | PUT | $820.00 | 307 | -99 | -24.38% |
05/16/2025 | PUT | $800.00 | 1,124 | -204 | -15.36% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 2.74% | 26M | 11.45B |
Vanguard 500 Index Fund | 1.92% | 18.23M | 8.03B |
Vanguard/Primecap Fund | 1.56% | 14.85M | 6.54B |
Fidelity 500 Index Fund | 0.91% | 8.65M | 3.81B |
SPDR S&P 500 ETF Trust | 0.90% | 8.54M | 3.76B |
Vanguard Specialized-Health Care Fund | 0.80% | 7.64M | 3.37B |
iShares Core S&P 500 ETF | 0.74% | 7.04M | 3.1B |
Washington Mutual Investors Fund | 0.73% | 6.95M | 3.06B |
Growth Fund Of America Inc | 0.71% | 6.7M | 2.95B |
Select Sector SPDR Fund-Health Care | 0.67% | 6.41M | 2.82B |
One of the Largest Teacher Pension Funds in the U.S. Sold Nvidia, Tesla, and Apple and Piled Into a Popular Pharmaceutical Stock Up 395% Over the Last 5 Years
05/08 06:05 pm
The Motley Fool
Read morePost-Earnings Dip: Why This Beaten-Down Stock Is a No-Brainer Buy
05/08 09:05 am
The Motley Fool
Read moreWhy Viking Therapeutics Stock Surged Nearly 20% Higher in April
05/06 04:33 am
The Motley Fool
Read moreLilly declares second-quarter 2025 dividend
05/05 12:47 pm
Benzinga
Read more3 No-Brainer Stocks to Buy in May
05/05 06:45 am
The Motley Fool
Read moreIs the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
05/04 04:49 am
The Motley Fool
Read moreWall Street Eyes 8th Positive Day As S&P 500 Recoups Tariff-Led Losses, Bitcoin Rallies To $97,000: What's Driving Markets Thursday? (CORRECTED)
05/01 02:42 pm
Benzinga
Read moreWhy Eli Lilly Stock Is Sinking Today
05/01 12:49 pm
The Motley Fool
Read moreWhy Novo Nordisk Stock Popped Today
05/01 11:11 am
The Motley Fool
Read more1 Beaten-Down Stock to Buy and Hold for 10 Years
05/01 05:47 am
The Motley Fool
Read moreMetastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight
04/30 01:00 pm
GlobeNewswire Inc.
Read moreEli Lilly's Stock Is Up 15% This Year, and Here's Why It Could Take Off Even More
04/30 05:50 am
The Motley Fool
Read moreWhy Viking Therapeutics Stock Popped Again Today
04/29 12:24 pm
The Motley Fool
Read moreHims & Hers Stock Surges As It Collaborates With Novo Nordisk To Sell Weight Loss Drug Wegovy On Its Platform
04/29 12:13 pm
Benzinga
Read moreThe S&P 500 Is Doing Something That Hasn't Been Seen in Nearly 100 Years. Here Are the 10 Most Important Stocks to Keep an Eye On.
04/29 07:30 am
The Motley Fool
Read moreWhy Viking Therapeutics Stock Popped Today
04/28 11:06 am
The Motley Fool
Read moreWhy Novo Nordisk Stock Dropped Today
04/25 10:58 am
The Motley Fool
Read moreViking Therapeutics EPS Miss Overlooked as Long-Term Pipeline Gains Focus
04/25 09:19 am
Investing.com
Read moreEli Lilly Nails Oral GLP-1 Trial — Here’s What It Means for the Stock
04/23 11:47 am
Investing.com
Read moreIs Eli Lilly Stock Going to $900? 1 Wall Street Analyst Thinks So.
04/23 06:55 am
The Motley Fool
Read moreNovo Nordisk Investors Just Got Terrible News. Should You Sell the Stock?
04/23 05:50 am
The Motley Fool
Read moreIs Eli Lilly Stock a Buy?
04/23 05:07 am
The Motley Fool
Read moreWhy Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday
04/22 05:37 pm
The Motley Fool
Read moreRoche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs
04/22 03:21 pm
Benzinga
Read moreParkinson’s Disease Therapeutic Domain Projected to See Transformational Growth Across the 7MM During the Study Period (2020–2034) | DelveInsight
04/22 01:00 pm
GlobeNewswire Inc.
Read more3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold
04/22 09:53 am
The Motley Fool
Read moreDown 61%, Is Novo Nordisk Stock Worth Buying on the Dip?
04/21 09:15 am
The Motley Fool
Read moreDid Eli Lilly Just Say Checkmate to Novo Nordisk?
04/21 04:30 am
The Motley Fool
Read morePrediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock
04/20 06:20 am
The Motley Fool
Read moreIs Eli Lilly Stock a Buy Right Now?
04/19 04:05 pm
The Motley Fool
Read moreEli Lilly's Experimental Weight Loss Pill Succeeded in Its First Pivotal Trial. Is It Time to Buy?
04/19 03:23 am
The Motley Fool
Read moreWhere Will Eli Lilly Be in 5 Years?
04/18 04:51 am
The Motley Fool
Read moreAtopic Dermatitis Drugs Market Forecast 2025-2034 | Rising Drug Approvals and Clinical Trial Successes Propel Revenue Growth, Making Atopic Dermatitis a High-Growth Market
04/18 04:26 am
GlobeNewswire Inc.
Read moreWall Street Rebounds, Eli Lilly Rallies, UnitedHealth Group Plummets: What's Driving Markets Thursday?
04/17 02:05 pm
Benzinga
Read moreAvoid The Mistake Countless Investors And Advisors Are Making, Oral Weight Loss Drug Is Almost Here
04/17 12:35 pm
Benzinga
Read moreDown 71%, Should You Buy the Dip on Viking Therapeutics Stock?
04/15 10:15 am
The Motley Fool
Read moreWhy Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
04/14 11:12 am
The Motley Fool
Read moreNovartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties
04/11 09:36 am
Benzinga
Read moreVerve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
04/11 07:00 am
GlobeNewswire Inc.
Read moreInjectable Drug Delivery Devices Market Size to Reach USD 1,217 Bn by 2034: Statifacts
04/10 11:00 am
GlobeNewswire Inc.
Read moreBiopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline
04/10 05:59 am
GlobeNewswire Inc.
Read moreDr. Oz Officially Confirmed as Head of the Centers for Medicare and Medicaid Services. Here's What Retirees Need to Know So Far.
04/09 05:44 am
The Motley Fool
Read moreAugustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors
04/09 01:00 am
GlobeNewswire Inc.
Read more3 Dividend Stocks to Buy and Hold for the Next Decade
04/06 06:44 am
The Motley Fool
Read moreWhy Hims & Hers Health Stock Couldn't Beat the Market Today
04/02 06:18 pm
The Motley Fool
Read moreWhy April Could Be a Huge Month for Eli Lilly Stock
04/02 06:46 am
The Motley Fool
Read morePersonalized Medicine Market Growth Trends 2025-2033: Transition to Customized Medical Care, Developments in Bioinformatics and Genomics, Growing Prevalence of Chronic Diseases
04/02 04:52 am
GlobeNewswire Inc.
Read more1 No-Brainer Vanguard S&P ETF to Buy Right Now for Less Than $1,000
04/01 10:15 am
The Motley Fool
Read moreWhere Will Eli Lilly Be in 1 Year?
04/01 05:37 am
The Motley Fool
Read moreEli Lilly's Cholesterol Drug Reduces Genetic Heart Disease Risk Factor By 93.9%
03/31 12:39 pm
Benzinga
Read more